Lee:Literature Proteasomes: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
Line 31: | Line 31: | ||
==LMP2/7== | ==LMP2/7== | ||
# pmid=9419215 | |||
# | # pmid=12456675 (C-terminal Myc and FLAG tags for MECL, LMP2,Delta, Z) | ||
# | # pmid=10329130 (modification of prepeptide sequence) | ||
# | # pmid=10363659 | ||
# | # pmid=9321388 (GFP fusion) | ||
# | # pmid=18728217 | ||
# | # pmid=19525961 | ||
# | |||
==Resistance mechanisms for proteasome inhibitors== | ==Resistance mechanisms for proteasome inhibitors== | ||
Line 45: | Line 44: | ||
# Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008 Aug;326(2):[http://jpet.aspetjournals.org/content/326/2/423.full.pdf+html 423-31]. (pmid=18502982) | # Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008 Aug;326(2):[http://jpet.aspetjournals.org/content/326/2/423.full.pdf+html 423-31]. (pmid=18502982) | ||
# Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008 Jan 1;103(1):[http://onlinelibrary.wiley.com/doi/10.1002/jcb.21405/pdf 270-83]. (pmid=17516511) | # Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008 Jan 1;103(1):[http://onlinelibrary.wiley.com/doi/10.1002/jcb.21405/pdf 270-83]. (pmid=17516511) | ||
==Proteasome inhibitors in lung cancer== | |||
==Proteasome inhibitors in pancreatic cancer== | |||
==NF-kB== | ==NF-kB== | ||
#1 pmid=16889756 | #1 pmid=16889756 | ||
#2 pmid=16724054 | #2 pmid=16724054 | ||
#3 pmid=17183360 | #3 pmid=17183360 | ||
#4 pmid=16618413 | #4 pmid=16618413 | ||
==MDR1 & apoptosis, NF-kB== | ==MDR1 & apoptosis, NF-kB== |